A Comparative Efficacy Study: Treatment for Non-healing Diabetic Foot Ulcers

Stopped early · Not applicable

Conditions studied: Foot Ulcer, Diabetic

In brief

The primary objective of this study is to assess the effectiveness of MatriStem devices compared to cellular dermal replacement tissue, for the treatment of non-healing diabetic foot ulcers.

Key facts

Study ID

NCT01858545

Run by

Integra LifeSciences Corporation

People needed

56

Starts

2013-05-01

Expected to finish

2015-12-01

Last updated by the study team

2021-04-15

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Carl t. Hayden Phoenix VA Medical Center — Phoenix, Arizona, United States
• Associated Foot & Ankle Specialists, PC — Phoenix, Arizona, United States
• Center for Clinical Research Inc. — Castro Valley, California, United States
• Valley Vascular Surgery Associates — Fresno, California, United States
• Denver VA Medical Center — Denver, Colorado, United States
• Georgetown University Medical Center — Washington D.C., District of Columbia, United States
• Advanced Research Institute of Miami — Homestead, Florida, United States
• NewPhase Clinical Trials, Corp. — Miami Beach, Florida, United States
• Professional Health Care of Pinellas — St. Petersburg, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.